Both work by lessening your appetite, but some studies on Zepbound (tirzepatide) have shown that patients who take it lose more weight than with Wegovy
Off-label combination therapy carries inherent risks: unknown drug-drug interactions, unpredictable gastrointestinal side effect stacking, and potential for overdosing one pathway while underdosing another
In clinical studies, participants on Wegovy who achieved weight loss consumed between 1,100 and 1,800 calories per day
Gamify It If youd rather get creative with it, there are ways to turn your GLP-1 injection schedule into a game
This is particularly beneficial for individuals with absorption difficulties, such as those with pernicious anemia or gastrointestinal issues, as our injections bypass the digestive system to deliver B12 directly to the bloodstream
Yes, individuals with a history of allergies, atopic conditions like eczema or asthma, or previous reactions to GLP-1 medications appear to have a higher risk of developing urticaria whilst taking Mounjaro